vs
Brilliant Earth Group, Inc.(BRLT)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
Brilliant Earth Group, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍($124.4M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 4.1%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $5.7M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs 13.1%)
Brilliant Earth是2005年8月由贝丝·格斯坦与埃里克·格罗斯伯格创立的美国珠宝企业,总部位于加利福尼亚州旧金山,主打标注为合规溯源的钻石与其他宝石珠宝,该品牌推动了 ethical 珠宝市场的发展,2017年曾有媒体对其部分产地来源声明提出质疑。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
BRLT vs PBYI — 直观对比
营收规模更大
BRLT
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出23.6%
4.1%
自由现金流更多
PBYI
多$8.7M
$5.7M
两年增速更快
PBYI
近两年复合增速
13.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $124.4M | $75.5M |
| 净利润 | $-2.9M | — |
| 毛利率 | 55.9% | 69.3% |
| 营业利润率 | -0.0% | 22.7% |
| 净利率 | -2.3% | — |
| 营收同比 | 4.1% | 27.7% |
| 净利润同比 | -908.9% | — |
| 每股收益(稀释后) | $-0.20 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BRLT
PBYI
| Q4 25 | $124.4M | $75.5M | ||
| Q3 25 | $110.3M | $54.5M | ||
| Q2 25 | $108.9M | $52.4M | ||
| Q1 25 | $93.9M | $46.0M | ||
| Q4 24 | $119.5M | $59.1M | ||
| Q3 24 | $99.9M | $80.5M | ||
| Q2 24 | $105.4M | $47.1M | ||
| Q1 24 | $97.3M | $43.8M |
净利润
BRLT
PBYI
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $-107.0K | $8.8M | ||
| Q2 25 | $-166.0K | $5.9M | ||
| Q1 25 | $-466.0K | $3.0M | ||
| Q4 24 | $358.0K | — | ||
| Q3 24 | $-141.0K | $20.3M | ||
| Q2 24 | $185.0K | $-4.5M | ||
| Q1 24 | $139.0K | $-4.8M |
毛利率
BRLT
PBYI
| Q4 25 | 55.9% | 69.3% | ||
| Q3 25 | 57.6% | 77.7% | ||
| Q2 25 | 58.3% | 76.5% | ||
| Q1 25 | 58.6% | 77.1% | ||
| Q4 24 | 59.6% | 76.4% | ||
| Q3 24 | 60.8% | 63.9% | ||
| Q2 24 | 60.8% | 77.4% | ||
| Q1 24 | 59.9% | 75.5% |
营业利润率
BRLT
PBYI
| Q4 25 | -0.0% | 22.7% | ||
| Q3 25 | -0.6% | 17.6% | ||
| Q2 25 | -1.1% | 12.7% | ||
| Q1 25 | -3.8% | 8.7% | ||
| Q4 24 | 2.0% | 22.6% | ||
| Q3 24 | -1.1% | 27.4% | ||
| Q2 24 | 1.1% | -4.6% | ||
| Q1 24 | 0.9% | -5.3% |
净利率
BRLT
PBYI
| Q4 25 | -2.3% | — | ||
| Q3 25 | -0.1% | 16.2% | ||
| Q2 25 | -0.2% | 11.2% | ||
| Q1 25 | -0.5% | 6.5% | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | -0.1% | 25.2% | ||
| Q2 24 | 0.2% | -9.6% | ||
| Q1 24 | 0.1% | -11.0% |
每股收益(稀释后)
BRLT
PBYI
| Q4 25 | $-0.20 | $0.26 | ||
| Q3 25 | $-0.01 | $0.17 | ||
| Q2 25 | $-0.01 | $0.12 | ||
| Q1 25 | $-0.03 | $0.06 | ||
| Q4 24 | $0.02 | $0.40 | ||
| Q3 24 | $-0.01 | $0.41 | ||
| Q2 24 | $0.01 | $-0.09 | ||
| Q1 24 | $0.01 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $79.1M | $97.5M |
| 总债务越低越好 | $0 | $22.7M |
| 股东权益账面价值 | $12.3M | $130.3M |
| 总资产 | $200.9M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
BRLT
PBYI
| Q4 25 | $79.1M | $97.5M | ||
| Q3 25 | $73.4M | $94.4M | ||
| Q2 25 | $133.6M | $96.0M | ||
| Q1 25 | $147.3M | $93.2M | ||
| Q4 24 | $161.9M | $101.0M | ||
| Q3 24 | $152.7M | $96.7M | ||
| Q2 24 | $152.2M | $96.8M | ||
| Q1 24 | $147.5M | $107.2M |
总债务
BRLT
PBYI
| Q4 25 | $0 | $22.7M | ||
| Q3 25 | $0 | $34.0M | ||
| Q2 25 | $34.5M | $45.3M | ||
| Q1 25 | $54.5M | $56.7M | ||
| Q4 24 | $55.7M | $68.0M | ||
| Q3 24 | $58.1M | $79.3M | ||
| Q2 24 | $58.0M | $90.7M | ||
| Q1 24 | $58.8M | $102.0M |
股东权益
BRLT
PBYI
| Q4 25 | $12.3M | $130.3M | ||
| Q3 25 | $12.0M | $115.3M | ||
| Q2 25 | $15.3M | $104.7M | ||
| Q1 25 | $14.9M | $97.1M | ||
| Q4 24 | $15.3M | $92.1M | ||
| Q3 24 | $14.5M | $71.1M | ||
| Q2 24 | $14.1M | $48.5M | ||
| Q1 24 | $13.3M | $51.0M |
总资产
BRLT
PBYI
| Q4 25 | $200.9M | $216.3M | ||
| Q3 25 | $203.0M | $202.9M | ||
| Q2 25 | $260.9M | $194.9M | ||
| Q1 25 | $269.6M | $196.2M | ||
| Q4 24 | $281.2M | $213.3M | ||
| Q3 24 | $273.2M | $220.7M | ||
| Q2 24 | $272.5M | $205.0M | ||
| Q1 24 | $268.2M | $214.1M |
负债/权益比
BRLT
PBYI
| Q4 25 | 0.00× | 0.17× | ||
| Q3 25 | 0.00× | 0.30× | ||
| Q2 25 | 2.26× | 0.43× | ||
| Q1 25 | 3.65× | 0.58× | ||
| Q4 24 | 3.63× | 0.74× | ||
| Q3 24 | 4.01× | 1.12× | ||
| Q2 24 | 4.13× | 1.87× | ||
| Q1 24 | 4.43× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $7.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $5.7M | $14.4M |
| 自由现金流率自由现金流/营收 | 4.6% | 19.1% |
| 资本支出强度资本支出/营收 | 1.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.8M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
BRLT
PBYI
| Q4 25 | $7.2M | $14.4M | ||
| Q3 25 | $608.0K | $9.7M | ||
| Q2 25 | $9.1M | $14.1M | ||
| Q1 25 | $-7.1M | $3.6M | ||
| Q4 24 | $14.1M | $15.6M | ||
| Q3 24 | $2.0M | $11.0M | ||
| Q2 24 | $7.3M | $1.0M | ||
| Q1 24 | $-5.8M | $11.2M |
自由现金流
BRLT
PBYI
| Q4 25 | $5.7M | $14.4M | ||
| Q3 25 | $-3.0K | $9.7M | ||
| Q2 25 | $7.9M | $14.1M | ||
| Q1 25 | $-7.9M | $3.6M | ||
| Q4 24 | $11.9M | $15.6M | ||
| Q3 24 | $674.0K | $11.0M | ||
| Q2 24 | $6.5M | $1.0M | ||
| Q1 24 | $-6.4M | — |
自由现金流率
BRLT
PBYI
| Q4 25 | 4.6% | 19.1% | ||
| Q3 25 | -0.0% | 17.7% | ||
| Q2 25 | 7.3% | 26.8% | ||
| Q1 25 | -8.4% | 7.7% | ||
| Q4 24 | 10.0% | 26.4% | ||
| Q3 24 | 0.7% | 13.7% | ||
| Q2 24 | 6.1% | 2.1% | ||
| Q1 24 | -6.5% | — |
资本支出强度
BRLT
PBYI
| Q4 25 | 1.2% | 0.0% | ||
| Q3 25 | 0.6% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 1.8% | 0.0% | ||
| Q3 24 | 1.3% | 0.0% | ||
| Q2 24 | 0.8% | 0.0% | ||
| Q1 24 | 0.6% | 0.0% |
现金转化率
BRLT
PBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 39.36× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 39.51× | — | ||
| Q1 24 | -41.65× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRLT
| US | $120.3M | 97% |
| Non Us | $4.2M | 3% |
PBYI
暂无分部数据